title: Enhancement of 1,3-bis(2-chloroethyl)-1-nitrosourea resistance by gamma-irradiation or drug pretreatment in rat hepatoma cells.
abstract: Treatment of rat hepatoma cells (H4 cells) with various DNA-damaging agents increases the number of O6-methylguanine-DNA-methyltransferase (transferase) molecules per cell. Because the cellular resistance to chloroethylnitrosoureas depends on the number of transferase molecules, we studied the influence of pretreatment with gamma-irradiation, cis-dichlorodiammineplatinum(II), or 2-methyl-9-hydroxyellipticinium on the sensitivity of H4 cells to 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU). The BCNU resistance depends on the gamma-ray dose and increases with time after irradiation: it is maximum when the drug is added 48 h after irradiation, which corresponds to the maximum enhancement of the transferase activity in the cells. Pretreatment with a single dose of cis-dichlorodiammineplatinum(II) or 2-methyl-9-hydroxyellipticinium also increases the cellular resistance to BCNU. This resistance is not due to a modification of the alkylation of the cellular DNA in the pretreated cells but is related to the increased transferase activity, as it is no longer observed when this activity is depleted by incubating the pretreated cells with the free base O6-methylguanine before BCNU treatment. These results suggest that tumor cells surviving after gamma-irradiation or drug treatment may become resistant to chemotherapy with chloroethylnitrosoureas.
authors.affiliation: Groupe Radiochimie de l'ADN, Unité 247 INSERM, Institut Gustave Roussy, Villejuif, France.
authors.forename: Y
authors.initials: Y
authors.lastname: Habraken
authors.forename: F
authors.initials: F
authors.lastname: Laval
mesh_terms: D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology; D006528:Carcinoma, Hepatocellular / Q000628:therapy*; D002330:Carmustine / Q000494:pharmacology*; D002945:Cisplatin / Q000494:pharmacology; D003131:Combined Modality Therapy; D004307:Dose-Response Relationship, Radiation; D004351:Drug Resistance / Q000528:radiation effects*; D004357:Drug Synergism; D004611:Ellipticines / Q000494:pharmacology; D005720:Gamma Rays; D008113:Liver Neoplasms / Q000628:therapy*; D008780:Methyltransferases / Q000096:biosynthesis; D019853:O(6)-Methylguanine-DNA Methyltransferase; D051381:Rats; D013997:Time Factors; D014407:Tumor Cells, Cultured
chemical_list: D000970:Antineoplastic Agents; D004611:Ellipticines; C027767:elliptinium; D008780:Methyltransferases; D019853:O(6)-Methylguanine-DNA Methyltransferase; D002945:Cisplatin; D002330:Carmustine